Here are six observations:
1. The growing number of neurological disorder cases, an influx of new neurosurgical devices and a boost in awareness about new technologies will spur market growth.
2. The introduction of neurointerventional technology will also drive the global market.
3. Neurostimulation devices capture the greatest market share due to clinical data supporting the devices’ safety and efficacy.
4. The Americas will continue to dominate the global market, due to an increased number of patients who receive neurosurgical procedures in the U.S.
5. The market in the Asia-Pacific region will likely hit $2.4 billion by 2023, growing at a 13 percent CAGR.
6. Key device companies include Boston Scientific, DePuy Synthes, Integra LifeSciences, Medtronic and Stryker.
More articles on devices:
5 things to know about Medtronic CEO Omar Ishrak
Spine Wave, Life Spine & more: 3 device company launches, releases
Astura Medical announces initial cases and full commercial release for BRIDALVEIL OCT stabilization system
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
